Assessment of 25-Year Survival of Women With Estrogen Receptor–Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy
Fuente: https://jamanetwork.com/
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
Fuente :https://doi.org
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
Fuente: Choi, S.B.; Park, J.M.; Ahn, J.H.; Go, J.; Kim, J.; Park, H.S.; Kim, S.I.; Park, B.W.; Park, S.
Breast Cancer Research and Treatment,
Vol. 192 Nr. 2 Páginas: 343 – 352 Fecha de publicación: 01/04/2022
Gentileza Dr. Antonio Lorusso
Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer
Fuente: Patel, R.; Li, Z.; Zimmerman, B.S.; Fink, M.Y.; Wells, J.D.; Zhou, X.; Ayers, K.; Redfern, A.; Newman, S.; Schadt, E.; Oh, W.K.; Chen, R.; Tiersten, A
Breast Cancer Research and Treatment, Vol. 192 Nr. 2 Páginas: 313 - 319Fecha de publicación: 01/04/2022
Gentileza Dr. Antonio Lorusso
Definition of inflammatory breast cancer: common diagnostic criteria proposed to guide treatment and research.
Fuente: Jagsi, R.; Mason, G.; Overmoyer, B.A.; Woodward, W.A.; Badve, S.; Schneider, R.J.; Lang, J.E.; Alpaugh, M.; Williams, K.P.; Vaught, D.; Smith, A.; Smith, K.; Miller, K.D.; Susan G. Komen
IBCRF IBC Collaborative in partnership with the Milburn, Foundation. Breast Cancer Research and Treatment, Vol. 192 Nr. 2 Páginas: 235 - 243 -
Fecha de publicación: 01/04/2022
Gentileza Dr. Antonio Lorusso
The Breast Cancer Screening and Timing of Breast MRI—Experience in a Genetic High-Risk Screening Clinic in a Comprehensive Cancer Center
Fuente:
https://www.mdpi.com/1718-7729/29/3/171/htm
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947675/
Downstream Mammary and Extramammary Cascade Services and Spending Following Screening Breast Magnetic Resonance Imaging vs Mammography Among Commercially Insured Women
Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)
Fuentes:
https://link.springer.com/article/10.1007/s00330-022-08617-6
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Fuente: Journal of Clinical Oncology / https://ascopubs.org/doi/full/10.1200/JCO.20.03399
Más Artículos...
- Quimioterapia neoadyuvante, terapia endocrina y terapia dirigida para el cáncer de mama
- Uso de anastrozol para la prevención del cáncer de mama (IBIS-II): resultados a largo plazo de un ensayo controlado aleatorio
- Mastectomía bilateral en mujeres con cáncer de mama unilateral. Una Revisión
- Efecto del cribado mamográfico a partir de los 40 años sobre la mortalidad por cáncer de mama (ensayo UK Age): resultados finales de un ensayo controlado y aleatorizado